Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds

In August 2020, the Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for COVID-19 convalescent plasma (CCP) specified 12 authorized serologic assays and associated assay-specific cutoff values for the selection of high-titer CCP for use in hospitalized patients. The criteria used...

Descripción completa

Detalles Bibliográficos
Autores principales: Larkey, Nicholas E., Ewaisha, Radwa, Lasho, Michael A., Roforth, Matthew M., Granger, Dane, Jerde, Calvin R., Wu, Liang, Gorsh, Amy, Klassen, Stephen A., Senefeld, Jonathon W., Joyner, Michael J., Baumann, Nikola A., Theel, Elitza S., Mills, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430146/
https://www.ncbi.nlm.nih.gov/pubmed/35862939
http://dx.doi.org/10.1128/spectrum.01154-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430146/
https://www.ncbi.nlm.nih.gov/pubmed/35862939
http://dx.doi.org/10.1128/spectrum.01154-22

Ejemplares similares